Log in
FRA:BAYN

Bayer Stock Forecast, Price & News

€53.47
-0.94 (-1.73 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
€53.05
Now: €53.47
€54.76
50-Day Range
€53.86
MA: €56.15
€57.98
52-Week Range
€91.58
Now: €53.47
€123.82
Volume3.34 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University to jointly identify new drug targets for the treatment of pulmonary diseases, such as idiopathic pulmonary fibrosis. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Read More
Bayer logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-214-301

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees111,015
Next Earnings DateN/A
OptionableNot Optionable
€53.47
-0.94 (-1.73 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bayer (FRA:BAYN) Frequently Asked Questions

How has Bayer's stock price been impacted by COVID-19?

Bayer's stock was trading at €56.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BAYN stock has decreased by 4.6% and is now trading at €53.47.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Bayer?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Bayer
.

What price target have analysts set for BAYN?

17 brokers have issued twelve-month price objectives for Bayer's stock. Their forecasts range from €59.00 to €110.00. On average, they anticipate Bayer's share price to reach €81.19 in the next year. This suggests a possible upside of 51.8% from the stock's current price.
View analysts' price targets for Bayer
.

Who are some of Bayer's key competitors?

What other stocks do shareholders of Bayer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include Hawkins (HWKN), CA (CA), Bayer (BAYRY), Basf (BAS), General Electric (GE), BlackRock (BLK), Coca-Cola (KO), Alibaba Group (BABA), Allianz (ALV) and Daimler (DAI).

Who are Bayer's key executives?

Bayer's management team includes the following people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
  • Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)

What is Bayer's stock symbol?

Bayer trades on the FRA under the ticker symbol "BAYN."

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €53.47.

What is Bayer's official website?

The official website for Bayer is www.bayer.de.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.